跳至主要内容
临床试验/NCT01684852
NCT01684852已完成不适用

Non Interventional Study to Evaluate the Efficacy and Tolerability of Ectoin Containing Ophthalmic Solution (BAT04) Compared to HA Eye Drops in the Treatment of Dry Eye Disease

Bitop AG5 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2012年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Bitop AG
入组人数
64
试验地点
5
主要终点
Tear Break Up Time

研究概览

简要总结

This is a comparative, open label, parallel group, non interventional study to further demonstrate the efficacy and tolerability of BAT04. In addition the efficacy and safety shall be compared to Hyaluronic acid (HA)-Product. The patient applies BAT04 or HA-Product according to the instructions for use six times daily in both eyes over a period of 28 days. Response to treatment is recorded at day 28.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female person aged 18 years
  • Demonstrated mild to moderate keratoconjunctivitis sicca ( "dry eye")
  • Acute symptoms of dry eye: DEWS 1-3
  • tear break-up time TBUT <10s
  • agreement to abide by the routinely provided doctor's appointment for follow-up (reflected in the planned visits of observation plan resist)

排除标准

  • inflammation of the anterior segment or trauma
  • Contact lens wearers
  • Any disease that can, in the opinion of the treating physician to affect the outcome of the study.
  • Patients with known intolerance to one of the substances used
  • Surgical procedures to the eyes in the last 6 weeks before inclusion in the trial
  • patients with addictive disorders or substance abuse fallow in the past 12 months, as well as persons incapable of giving consent

结局指标

主要结局

Tear Break Up Time

时间窗: V1 and V2

次要结局

未报告次要终点

研究者

发起方
Bitop AG
申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验